Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07208747Completed

Evaluating an Intelligent Module for Pressure Injury Nursing Management

Role: lead

NCT07185243Not ApplicableRecruiting

A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.

Role: collaborator

NCT07183293Not ApplicableNot Yet Recruiting

A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis

Role: lead

NCT04198207Completed

The Effectiveness and Safety of Vagus Nerve Stimulation for TRE

Role: collaborator

NCT04325152Not ApplicableCompleted

Clip-assisted Fixation to Prevent Migration of Fully Covered Self-expandable Metal Stent in Patients Undergoing ERCP

Role: collaborator

NCT05824390Phase 4Unknown

A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy

Role: collaborator

NCT04101097Completed

Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy

Role: collaborator

All 7 trials loaded